Overview

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of KDX-0811(Dexrazoxane) in the treatment of accidental extravasation of anthracycline anti-cancer agents.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Kissei Pharmaceutical Co., Ltd.

Treatments:

Antineoplastic Agents
Dexrazoxane
Razoxane